EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Thyrotroph Pituitary Neuroendocrine Tumors: Molecular Pathology, Diagnostic Challenges, and Receptor-Targeted Therapeutic Strategies

Kazunori Kageyama iD, Keisuke Sato, Mizuki Tasso, Yuki Nakada

Cancers · 04.03.2026 · 18 (5) · 838

DOI: 10.3390/cancers18050838 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 04.03.2026. Verfasst von Kazunori Kageyama und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diabetes, Metabolism and Endocrinology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, 1-15-1 Fukumuro, Sendai 983-85…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thyrotroph pituitary neuroendocrine tumors (PitNETs) are rare functional pituitary tumors characterized by autonomous secretion of thyroid-stimulating hormone (TSH), leading to central hyperthyroidism. Under the 2022 World Health Organization classification, these tumors are defined as PIT1-lineage PitNETs, reflecting lineage-specific differentiation and improving pathological accuracy. Clinically, thyrotroph PitNETs often present as macroadenomas with invasive growth, making complete surgical resection challenging and necessitating multimodal treatment strategies. From a molecular oncology perspective, thyrotroph PitNETs lack recurrent driver mutations and instead exhibit heterogeneous alterations involving dysregulated cell-cycle control, impaired thyroid hormone-mediated negative feedback, and aberrant growth factor signaling. Immunohistochemically, tumor cells express PIT1 and TSH and show strong membranous expression of somatostatin receptor subtype 2, providing a biological rationale for somatostatin receptor ligand -based therapy. Somatostatin receptor ligands play a central role in the management of thyrotroph PitNETs as preoperative, adjuvant, or primary treatment and achieve effective hormonal control and tumor stabilization or shrinkage in many patients. Accurate differentiation between thyrotroph PitNETs and resistance to thyroid hormone β is essential, as these entities share biochemical features but require fundamentally different management. Advances in lineage-based tumor classification, receptor profiling, and molecular pathology have refined diagnostic strategies and enabled a more personalized, tumor-oriented therapeutic approach. This review highlights current insights into the tumor biology and treatment of thyrotroph PitNETs and discusses future perspectives for receptor-targeted and molecularly informed therapies.

Schlagwörter

Stichwörter der Autor:innen

PIT1TSHomahyperthyroidismpituitary neuroendocrine tumorsomatostatin receptorthyrotroph

Autor:innen und Institutionen

  • Division of Diabetes, Metabolism and Endocrinology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, 1-15-1 Fukumuro, Sendai 983-8536, Japan.

ORCID-Profile: Kazunori Kageyama

Förderung

  • JSPS KAKENHI

Zitieren

APA

Kageyama, K., Sato, K., Tasso, M., & Nakada, Y. (2026). Thyrotroph Pituitary Neuroendocrine Tumors: Molecular Pathology, Diagnostic Challenges, and Receptor-Targeted Therapeutic Strategies. Cancers, 18(5), 838. https://doi.org/10.3390/cancers18050838

Vancouver

Kageyama K, Sato K, Tasso M, Nakada Y. Thyrotroph Pituitary Neuroendocrine Tumors: Molecular Pathology, Diagnostic Challenges, and Receptor-Targeted Therapeutic Strategies. Cancers. 2026;18(5):838. doi:10.3390/cancers18050838

BibTeX
@article{Kageyama2026,
  author = {Kageyama, Kazunori and Sato, Keisuke and Tasso, Mizuki and Nakada, Yuki},
  title = {Thyrotroph Pituitary Neuroendocrine Tumors: Molecular Pathology, Diagnostic Challenges, and Receptor-Targeted Therapeutic Strategies},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {5},
  pages = {838},
  doi = {10.3390/cancers18050838}
}
Kostenlos starten →